Bladder cancer, Kidney cancer, Transitional cell cancer
Results
Phase 2
This trial looked at a drug called sunitinib alongside chemotherapy for transitional cell cancer. It was for people whose cancer had grown into surrounding tissue (is ) or had spread to another part of their body. The trial was supported by Cancer Research UK.
Transitional cells (also called urothelial cells) are a part of the urinary system. The urinary system filters waste products from the blood and makes urine. Transitional cells line the centre of each kidney (renal pelvis), the bladder and the tubes that drain urine from the kidneys to the bladder (ureters). So you can get transitional cell cancer in the kidney, bladder or ureters.
Recruitment start: 20 July 2009
Recruitment end: 1 February 2013
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Thomas Geldart
Cancer Research UK
Cardiff University
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Pfizer
Wales Cancer Trials Unit
This is Cancer Research UK trial number CRUK/07/044.
Last reviewed: 16 September 2015
CRUK internal database number: 4009